Open AccessSafety and Tolerability of Sodium Glucose Co-transporter -2 Inhibitors (SGLT2i) During Ramadan Fasting
Author(s) -
Elsayed A. Eid,
Abdelaziz M. Hussein,
Hossam A. Ghazy
Publication year - 2021
Publication title -
clinical diabetology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.152
H-Index - 4
eISSN - 2450-8187
pISSN - 2450-7458
DOI - 10.5603/dk.a2021.0048
Subject(s) - medicine , glimepiride , tolerability , canagliflozin , metformin , hypoglycemia , dapagliflozin , empagliflozin , diabetes mellitus , type 2 diabetes , adverse effect , gastroenterology , endocrinology , insulin